What Sai Group does

SAIGroup is a Palo Alto–based private investment firm founded in 2017 by Dr. Romesh Wadhwani, who has committed up to $1 billion of personal capital to build a portfolio of enterprise AI leaders. The firm operates a platform-plus-portfolio model: it acquires and operates majority stakes in vertical AI software businesses and underwrites them with a shared underlying technology foundation. SAIGroup's stated investment criteria target majority acquisitions of software, data, analytics, and tech-enabled services businesses with ARR between $5M and $150M, breakeven-to-profitable profiles, and referenceable enterprise customer bases.

The unifying technical asset is the Eureka AI platform, which combines predictive and generative AI capabilities (using unsupervised, supervised, and semi-supervised ML techniques) and is deployed across all five portfolio companies: SymphonyAI (enterprise AI for retail, CPG, financial services, manufacturing, media, and IT operations, with 1,000+ enterprise clients), ConcertAI (real-world data and AI for life sciences and healthcare, serving 1,300+ hospital systems and 35 of the top life sciences companies), RhythmX AI (generative AI-native precision care for clinicians), Get Well (digital patient engagement for 10M+ annual patient interactions across 1,000+ healthcare organizations, acquired July 2024), and JazzX AI (enterprise work automation launched October 2023). ConcertAI's healthcare data assets — covering 300M patients, 4.4B annual claims, and 1.8M healthcare professionals at 300,000+ facilities — anchor a substantial data moat.

The business model is an enterprise SaaS subscription model across portfolio companies, with custom-priced annual contracts negotiated against scope, data volume, users, and deployment complexity. GTM is primarily direct enterprise field sales supported by strategic alliances with Microsoft (Azure marketplace and Dragon Copilot integration), EY, TCS, and L&T Technology Services, alongside international reseller partners. Combined portfolio revenue approached $500M in 2022 with ARR growing over 30% annually, and the portfolio collectively employs more than 4,000 engineers, data scientists, and domain experts. SAIGroup itself remains a tightly held holding company (11–50 employees), with the investment team led by Senior Investment Partners Pradyut Shah and Michael Healy under Wadhwani's continued control.

Name

Sai Group

Legal name

SAIGroup

Website

https://saigroup.ai

Company type

Private

Founded year

2017

Operating status

Operating

Headcount range

11–50 employees

Short description

SAIGroup is a private Palo Alto investment firm founded by Dr. Romesh Wadhwani that builds and acquires enterprise AI leaders — SymphonyAI, ConcertAI, RhythmX AI, Get Well, and JazzX AI — sharing a unified Eureka AI platform to serve healthcare, retail, financial services, manufacturing, and IT operations customers globally.

Ownership category

akta.pro rank

Product category

Enterprise AI Software

NAICS

Management of Companies and Enterprises (551), Management of Companies and Enterprises (55111)

SIC

Services-Management Consulting Services (8742), Finance Services (6199)

akta.pro primary industry

Corporate Innovation & Technology Scouting Units (with investment mandate) (FSANAHAI)

akta.pro secondary industries

AI Governance, Risk & Compliance (GRC) Platforms (HDAAAMAA), Hospital Shared Services, GPOs & System Support Organizations (HLAFAAAO), Enterprise AI Governance, Risk & Compliance Platforms (Model Risk, Audit, Policies) (HDAEANAE)

Keywords

• Enterprise AI software
• AI investment firm
• Healthcare AI platform
• Predictive analytics SaaS
• Vertical AI solutions

Headquarters

HQ city

Palo Alto

HQ country

United States

HQ region

North America

Offices2 records

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Marketing or Sales, Operations, Infrastructure

Revenue model

1. Enterprise AI SaaS Subscriptions: SAIGroup portfolio companies (SymphonyAI, ConcertAI, RhythmX AI, Get Well) generate revenue primarily through enterprise SaaS subscriptions. SymphonyAI and ConcertAI deliver AI solutions that transform industries on a subscription basis to large enterprise clients.
2. Investment Firm Management: SAIGroup operates as a private investment firm investing in businesses with potential to become leaders in enterprise AI. Principal owner Dr. Romesh Wadhwani has committed up to $1 billion in investment capital. Revenue is generated through portfolio company growth, exits, and operational value creation.

Pricing tiers

Go-to-market motion3 records

Distribution channels4 records

Marketing channels6 records

Core offering

SAIGroup is a private investment firm that builds and acquires enterprise AI software companies. Through wholly owned portfolio companies — SymphonyAI, ConcertAI, RhythmX AI, Get Well, and JazzX AI — it delivers vertical AI SaaS solutions for healthcare, retail/CPG, financial services, manufacturing, media, and IT operations, all powered by its proprietary Eureka AI platform combining predictive and generative AI.

Product overview

SAIGroup is a private investment firm that operates as a platform-plus-portfolio model, building leading enterprise AI businesses through its portfolio companies. The core EurekaAI platform provides the foundational predictive and generative AI technology that powers all portfolio products. The portfolio comprises five operating companies: SymphonyAI (enterprise AI for retail, financial services, manufacturing, media, and IT operations), ConcertAI (real-world data and AI for life sciences and healthcare), RhythmX AI (generative AI-native precision care for clinicians), Get Well (digital patient engagement), and JazzX AI (work automation). SymphonyAI itself contains multiple sub-brands including Sensa (financial crime prevention), Summit (IT service management), Industrial (manufacturing AI), and Retail CPG. ConcertAI includes TeraRecon (imaging AI), STAR, and Predictive Patient solutions. These products share the EurekaAI platform and data assets while targeting distinct vertical markets.

Differentiator

Problem solved

Functional benefit

Brands

• Eureka AI: SAIGroup's advanced predictive and generative AI platform used across portfolio companies
• SymphonyAI Sensa
• SymphonyAI Summit
• SymphonyAI Retail CPG
• SymphonyAI Industrial

Products and services

• SymphonyAI Enterprise AI platform serving over 1,000 leading enterprises across retail, CPG, financial services, manufacturing, media, and IT operations with AI-powered solutions for digital transformation.
• ConcertAI Real-world data and enterprise AI platform for life sciences and healthcare, accelerating clinical drug development, improving image interpretation and clinical decision-making across 1,300+ hospital systems and 35 top life sciences companies.
• RhythmX AI Precision Care Platform World's first native generative AI precision care platform enabling physicians to deliver hyper-personalized interventions and compassionate care through generative AI copilots and natural language interfaces.
• Get Well Digital patient engagement platform combining advanced AI navigation with high-touch care experiences, serving more than 10 million patients annually at over 1,000 hospitals and clinical partner sites.
• JazzX AI AI-powered platform for reimagining how work gets done through empowered automation and fluid intelligence, unlocking breakthrough productivity, efficiency, and innovation across the enterprise.
• SymphonyAI Sensa (Financial Crime Prevention) AI-powered financial crime prevention platform using NetReveal technology for anti-money laundering, fraud detection, and sanctions screening, reducing false positives by up to 70% for banks and financial institutions.
• SymphonyAI Summit (IT Service Management) IT and enterprise service management platform providing AI-powered IT service management, asset management, and workflow automation, rated 4.5/5 on Gartner Peer Insights.
• SymphonyAI Industrial AI platform for manufacturing operations including KPI 360, Batch 360, Vision 360, Performance 360, IRIS, and IRIS Workspace for process and discrete manufacturers, oil & gas, and automotive.
• SymphonyAI Retail CPG AI SaaS solutions for connected retail including supply chain optimization, category and space planning, and personalized customer experience, including CINDE AI for deep customer analytics.
• TeraRecon (ConcertAI) Advanced visualization and imaging AI platform for radiology, cardiology, neurology, and clinical research with Eureka Clinical AI capabilities including Cardio Suite and Neuro features.
• STAR (ConcertAI) Enterprise HIPAA-compliant AI solution providing actionable patient insights through advanced AI algorithms and data visualizations for optimized patient experiences and maximized brand value for life sciences companies.
• Predictive Patient (ConcertAI) AI solution that transforms millions of health and behavioral records and applies advanced AI models to improve patient experience from therapy initiation through adherence.
• Apex Enterprise IT Copilot Generative AI-based copilot for enterprise IT service management that resolves IT issues faster and delivers superior user experience and performance.
• IRIS Foundry AI-powered Industrial Data Ops Platform for manufacturing operations that enables data operations and analytics across industrial environments.
• SensaAI for Sanctions AI-based sanctions screening solution for risk detection and turbocharged sanctions screening as part of Sensa financial crime prevention suite.
• IRIS Workspace Live collaboration environment to analyze and troubleshoot industrial operations as part of the SymphonyAI Industrial portfolio.
• Media and Entertainment AI Copilot AI copilot for media and entertainment companies enabling content monetization, audience churn reduction, streaming analytics, and revenue optimization.
• Generative AI Investigator Copilot Generative AI copilot for financial crime investigators that increases investigator productivity by as much as 70% within the Sensa-NetReveal platform.
• KPI 360 AI and physics-driven KPI optimization solution for manufacturing operations within the SymphonyAI Industrial portfolio.
• Batch 360 and Vision 360 AI-based batch processing and vision solutions for high-quality manufacturing production within the SymphonyAI Industrial portfolio.

Quantifiable outcome

• Get Well solutions decreased readmission rates by over 40%
• +7 more outcomes

Named customers12 records

Segments6 records

Ideal customer profiles5 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability9 records

Feature4 records

Partnerships

15 partnerships are on record, tiered minor and core.

• L&T Technology ServicesminorImplementation/ SI/ Consulting Partner · 23 July 2024L&T Technology Services partnered with SymphonyAI to provide AI-based business transformation to global customers through Apex Enterprise Copilot, combining LTTS's engineering services with SymphonyAI's AI platform.
• Sentara HealthcoreStrategic or Co-development Partner · 22 February 2024Sentara Health tapped RhythmX AI to deploy generative AI-driven co-pilot for clinicians, marking a groundbreaking collaboration to forge the future of primary care with predictive and generative AI-driven solutions.
• Joe Petro (Advisor)minorOthers · 29 January 2024RhythmX AI welcomed Joe Petro, CVP of Microsoft Health & Life Sciences Solutions and Platforms, to its advisory board, strengthening the Microsoft relationship at the executive advisory level.
• MicrosoftcoreStrategic or Co-development Partner · 15 January 2024SymphonyAI and Microsoft formed a strategic generative AI collaboration for next-generation connected retail. Microsoft Azure AI powers SymphonyAI's generative AI capabilities. In October 2024, SymphonyAI was named Microsoft 2024 Business Transformation: AI Innovation Partner of the Year. RhythmX AI also collaborates with Microsoft to integrate its precision care platform into Dragon Copilot.
• Tata Consultancy Services (TCS)coreImplementation/ SI/ Consulting Partner · 10 January 2024SymphonyAI and TCS formed strategic partnership to create predictive and generative AI business applications. TCS brings global implementation and consulting capabilities to deploy SymphonyAI enterprise solutions across TCS's extensive client base.
• Memorial Sloan KetteringcoreStrategic or Co-development Partner · 14 November 2023ConcertAI partnered with Memorial Sloan Kettering for AI-powered imaging and clinical research, combining MSK's clinical expertise with ConcertAI's AI and data platforms for oncology research.
• Nathan Gnanasambandam (Advisor)minorOthers · 1 September 2023RhythmX AI welcomed former UnitedHealth Executive and HealthPointe Solutions CTO Nathan Gnanasambandam as Vice President of AI, bringing deep healthcare AI experience to RhythmX AI's precision care platform development.
• EY (Ernst & Young)coreStrategic or Co-development Partner · 10 August 2023EY announced a strategic alliance with SymphonyAI to help digitally transform organizations with generative AI-enabled retail and financial services platforms. EY brings consulting and implementation expertise to deploy SymphonyAI solutions at enterprise scale globally.
• Microsoft Health & Life SciencescoreStrategic or Co-development Partner · 1 June 2023RhythmX AI announced collaboration with Microsoft to integrate its precision care platform into Dragon Copilot, providing clinicians with real-time comprehensive patient data for hyper-personalized treatment.
• Caris Life SciencescoreStrategic or Co-development Partner · 9 January 2023ConcertAI and Caris Life Sciences formed a broad partnership creating an industry-leading molecular oncology research platform to accelerate drug development. The partnership was expanded in June 2023 to create the first-in-class, prospectively matched clinico-genomic research platform.
• NetReveal (from BAE Systems)coreTechnology or Integration · 12 July 2022SymphonyAI acquired NetReveal from BAE Systems, a financial crime detection business bringing approximately 200 large global financial services customers and leading technology for AML and fraud detection.
• 1010datacoreTechnology or Integration · 8 June 2022SymphonyAI acquired 1010data to expand enterprise AI capabilities in retail, CPG, and financial services. 1010data brings advanced analytics and data management capabilities that integrate with SymphonyAI's Eureka AI platform.
• TeraReconcoreTechnology or Integration · 9 November 2021ConcertAI integrated TeraRecon, a leading advanced visualization company, into its Eureka Clinical AI Platform, streamlining SaaS research and bolstering real-world evidence studies.
• 3MminorStrategic or Co-development Partner · 30 August 20213M expanded its partnership with SymphonyAI Industrial for digital automation and enterprise AI, combining 3M's industrial expertise with SymphonyAI's manufacturing AI solutions.
• Janssen (Johnson & Johnson)coreStrategic or Co-development Partner · 25 August 2021ConcertAI and Janssen partnered to address health disparities in clinical trials and advance diversity in clinical trial design. The partnership leverages real-world data to improve trial representativeness and patient outcomes.

Scale indicators12 records

Recent moves6 records

Expansion highlights6 records

Broad incumbents

• Bain Capital Tech Opportunities: Bain Capital's Tech Opportunities fund invests in growth-stage and established enterprise software and AI businesses. Comparable to SAIGroup in its willingness to take control positions in software companies with proven AI products and enterprise customer bases.
• Permira: Permira has a sizable technology investment practice focused on enterprise and vertical software. SAIGroup's thesis of building leading vertical-AI software businesses through majority acquisitions and operational improvement maps closely to Permira's approach.
• Insight Partners: Insight Partners is a global software investor spanning venture, growth, and buyouts. SAIGroup's focus on enterprise AI software with strong referenceable customer bases and rapid deployment is directly comparable to Insight's scale software investment thesis.
• Thoma Bravo: Thoma Bravo is one of the largest software-focused PE firms, taking majority control of vertical SaaS and enterprise software companies and operating them as a portfolio. Highly comparable to SAIGroup's strategy of acquiring majority stakes in enterprise AI software companies with strong recurring revenue and customer bases.
• Hg (Hg Capital): Hg is a PE firm focused on software and services businesses in the technology sector, particularly vertical SaaS. Comparable to SAIGroup in its preference for asset-light, recurring-revenue enterprise software platforms across multiple verticals.
• Vista Equity Partners: Vista Equity Partners is a leading software-focused PE firm that acquires and scales enterprise software businesses. SAIGroup's majority-acquisition model of ARR-generating AI software companies closely mirrors Vista's playbook, including the use of operating partner talent and platform integration.
• Silver Lake: Silver Lake is a large-cap technology-focused PE firm. While it typically targets much larger take-privates, its emphasis on deep-tech enterprise platforms makes it a relevant broad incumbent comparable to SAIGroup's enterprise AI thesis.

Direct peers

• Tempus AI: Tempus AI is a healthcare-focused AI and real-world data company serving oncologists, life sciences, and providers. Directly comparable to ConcertAI and RhythmX AI as a healthcare AI peer using large longitudinal patient datasets to deliver precision medicine and clinical decision support.
• Palantir Technologies: Palantir builds enterprise AI/data operating systems (Foundry, Gotham) used by large enterprises and government agencies. Comparable to SAIGroup's EurekaAI platform and ConcertAI's enterprise AI infrastructure for healthcare and life sciences customers.
• C3.ai: C3.ai is a public enterprise AI SaaS platform delivering pre-built AI applications across verticals including financial services, manufacturing, and healthcare. Directly comparable to SAIGroup's SymphonyAI as a horizontal AI platform monetized through vertical industry applications sold to large enterprises.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat6 records

Key risks5 records

Key highlights7 records

Customer concentration

• LinkedInlinkedin.com/company/sai-group-investments

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles14 records

Subsidiaries5 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A1 record

Investments1 record

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Sai Group